Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04476108 Completed - Clinical trials for Diabetic Peripheral Neuropathic Pain

Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain

Start date: July 15, 2020
Phase: Phase 2
Study type: Interventional

This study is being done to test the safety and efficacy of the study drug LY3016859 for the treatment of diabetic peripheral neuropathic pain. This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292) which is a protocol to accelerate the development of new treatments for chronic pain.

NCT ID: NCT04475848 Completed - Clinical trials for Autism Spectrum Disorder

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants

Start date: July 15, 2020
Phase: Phase 1
Study type: Interventional

This study will evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single- and multiple-ascending doses (SAD (Part 1) and MAD (Part 2)) and food effect (FE) of RO6953958 following oral administration in healthy male participants. Part 3 (Drug-drug interaction (DDI)) will assess the safety, tolerability, and effect of RO6953958 on the PK of the cytochrome P450 (CYP) 3A substrate midazolam.

NCT ID: NCT04475796 Completed - Clinical trials for Choledocholithiasis With Cholecystitis

Early Versus Delayed Laparoscopic Cholecystectomy Following ERCP in Concomitant Gallstones and Common Bile Duct Stones

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

The present study aimed to compare early and delayed laparoscopic cholecystectomy after ERCP for CBDs and gallstones.

NCT ID: NCT04475588 Completed - Covid19 Clinical Trials

Efficacy and Safety of Itolizumab in COVID-19 Complications

Start date: May 1, 2020
Phase: Phase 2
Study type: Interventional

Randomized, Parallel Group, Active Controlled Trial

NCT ID: NCT04474912 Completed - Clinical trials for Rheumatoid Arthritis (RA) and Osteoarthritis (OA)

Serum IL-17 Correlated With Inflammatory Changes in Osteoarthritis and Rheumatoid Arthritis

Start date: July 1, 2020
Phase:
Study type: Observational

The total number of the included subjects was 120 in 3 equal groups (RA, OA and control). All subject was subjected to serum IL17 level measurement. MSK US (of both wrists, MCPs, PIPs and DIPs) was done to all patients in RA and OA groups. Disease activity was measured by disease activity score (DAS28) for RA patients. Visual analogue scale for pain (VAS) was obtained from patients in RA and OA groups. Functional assessment was done using health assessment questionnaire (HAQ) for RA patients and the Australian/Canadian (AUSCAN) Osteoarthritis Hand Index for OA patients

NCT ID: NCT04474795 Completed - Clinical trials for Gestational Diabetes

Clinic to Community Connections - Broader Distribution

Start date: June 18, 2020
Phase: N/A
Study type: Interventional

This study addresses education needs in gestational diabetes care and followup at the staff and patient levels. In the initial phase, nurses and community health workers will complete specific training modules on gestational diabetes developed for this study. The effectiveness of the education modules will be evaluated through pre/post surveys of participants assessing diabetes knowledge, attitudes, and self-efficacy.

NCT ID: NCT04474704 Completed - Clinical trials for Preeclampsia With Severe Features

Use of Cheetah® Cardiac Monitoring System to Guide Discontinuation of Magnesium Sulfate in Women With Severe Preeclampsia

Start date: February 22, 2021
Phase: N/A
Study type: Interventional

This is a single site pilot randomized, controlled, trial randomizing patients with PE with severe features to one of 2 groups: - 24 hours of postpartum magnesium sulfate (current arbitrary standard of care) - Using the Cheetah® device to aid in an individualized duration of magnesium sulfate.

NCT ID: NCT04474093 Completed - Clinical trials for Dental Porcelain (MeSH Unique ID: D003776)

Monolithic CAD/CAM Single Tooth Ceramic Crowns

Start date: August 24, 2016
Phase: N/A
Study type: Interventional

With the development of Computer Aided Design and Computer Aided manufacturing (CAD / CAM) systems, all ceramic restorations have been used with high success rates during the past 30 years in order to eliminate the disadvantages of metal ceramic restorations. Based on these developments, in every passing days new ceramic materials has been added to dental market. The aim of the present study was evaluating clinical results of single-tooth ceramic crowns in the posterior region produced from three different monolithic ceramic materials.

NCT ID: NCT04473755 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

A Naturalistic Study of Functional Impairment for Individuals With ADHD in the Early Morning and Late Afternoon/Evening Hours

Start date: August 4, 2020
Phase:
Study type: Observational

The objective of this study is to assess the burden and impact of ADHD impairment in the early morning and late afternoon/evening hours for adolescents and young adults. Functional impairments will focus on the currently identified areas of functional impairment in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5, American Psychiatric Association, 2013) - namely, social, academic, and occupational functioning. This is necessary for two reasons: (1) the current literature on ADHD impairment and functioning is concentrated within elementary school children; and (2) studies of intervention effectiveness are typically concentrated during the school day. This current state of the literature ignores the obvious - as ADHD is a chronic disorder, it needs to be addressed as children grow into adolescence and young adulthood, and it needs to be remediated at times outside of the school day such as in the morning and late afternoon/evening. Therefore, the specific areas assessed in the present study will relate to driving, school, work, and family functioning. These are important areas to study, as the research literature has typically focused on elementary school and school-day behavior in assessments of symptom presentation, impairment, and treatment outcome. As individuals with ADHD grow older, the entire day becomes relevant in determinations of functioning (e.g., workdays may begin in the very early morning or last into the evening/night), and productivity can be assessed across waking hours rather than just across the elementary school day. Once areas of functional impairment in these times of day are determined, for this age group, treatment candidates can aim to address these treatment targets.

NCT ID: NCT04473742 Completed - Clinical trials for Positive Testing for ANA as a Marker of Systemic Autoimmune Diseases

Effects of Silica and Asbestos Fibres on the Efferocytosis Capacities of Macrophages

MacFibOsis
Start date: March 31, 2021
Phase: N/A
Study type: Interventional

Evaluation of the efferocytosis capacities of blood Monocyte Derived Macrophages (MDM) from patients with a history of asbestosis or silica exposure and comparison of these capacities with those of MDM from healthy donors.